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ABSTRACT: The combination of the speciﬁcity of antibodies
and the programmability of DNA nanotechnology has provided
the scientiﬁc community with a powerful tool to label and
unambiguously distinguish a large number of subcellular targets
using ﬂuorescence-based read-out methods. Whereas primary
antibodies are commercially available for a large class of targets, a
general stoichiometric site-selective DNA labeling strategy for this
aﬃnity reagent is lacking. Here we present a universal, site-
selective conjugation method using a small photo-cross-linkable
protein G adaptor that allows labeling of antibodies of diﬀerent
host species with a controlled number of short oligonucleotides
(ODNs). Importantly, we illustrate that this conjugation method can be directly performed on commercially available primary
antibodies on a small scale and without cross-reactivity towards bovine serum albumin. In addition, we present a general
benchtop-compatible strategy to purify DNA-labeled antibodies without a loss of function. The application of protein G-ODN-
labeled primary antibodies is demonstrated by employing three well-known methods for detecting subcellular targets using
ﬂuorescence read-out, including ﬂow cytometry, DNA-PAINT, and dSTORM. This work thus establishes a general and eﬃcient
platform for the synthesis of a library of unique ODN−antibody conjugates, facilitating the broader use of DNA-based
programmable tags for multiplexed labeling to identify subcellular features with nanometer precision and improving our
understanding of cellular structure and function.
■ INTRODUCTION
To unravel the structure, organization, and function of
subcellular components in a crowded environment, speciﬁc
orthogonal labeling of a large variety of biomolecules inside the
cell is essential. Currently, antibodies are the preferred aﬃnity
reagents for the visualization of subcellular components
because they oﬀer exquisite control over speciﬁcity and are
commercially available for a large class of targets. The
predictability of DNA nanotechnology has provided a powerful
tool for providing antibodies with unique, programmable labels
that allow detection via various ﬂuorescence-based read-out
methods.1 In general, read-out methods based on DNA have
the advantage that their coding capacity, in addition to a
number of spectrally distinct ﬂuorescent tags, relies on the
complementarity of unique oligonucleotide (ODN) sequences,
increasing the number of labels that can be simultaneously
used.2,3 As a result, multiple ﬂuorescence-based read-out
methods are available that rely on the reversible binding of
short imager strands,4,5 aﬃnity-mediated signal ampliﬁca-
tion,6,7 and DNA strand displacement.8−10 In addition,
advances in the ﬁeld of DNA nanotechnology have provided
a powerful tool for the design of well-deﬁned nanostructures,
the DNA origami technique.11−13 This development has
allowed the design of nanostructures that facilitate control
over optical properties (e.g., brightness, color) by the site-
speciﬁc incorporation of ﬂuorescently labeled ODNs.14,15
Combining the programmability of DNA nanotechnology
with the speciﬁcity of antibody labeling therefore facilitates the
design of programmable ﬂuorescent tags that have the ability
to label >100 subcellular targets and can be distinguished
unambiguously.
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Although primary antibodies are widely commercially
available, a general stoichiometric site-selective ODN labeling
strategy is missing. Traditionally, antibodies are functionalized
with a modiﬁed ODN that targets chemical groups present in
the native antibody (e.g., thiols and primary amines).16,17
However, this method lacks site-selectivity and stoichiometric
control and can therefore result in antibodies with diminished
binding capacity.18 Moreover, commercially available antibody
solutions contain protein stabilizers, bovine serum albumin
(BSA) in particular, which carry numerous functional groups
that directly compete for reaction with the functionalized
ODN. Several methods have been introduced to address these
limitations, involving the introduction of noncanonical amino
acids19 or speciﬁc labeling tags, including Snap-tags,20
HaloTags,21 and CLIP-tags.22 Additionally, coupling methods
targeting speciﬁc regions on the antibody have been
applied.23−26 However, these methods require genetic re-
engineering of the antibody, are limited by the speciﬁc host
species or subtype of the antibody, or are performed in the
absence of stabilizing proteins.
Here we present a general, benchtop-compatible strategy to
site-selectively label and purify commercially available primary
antibodies with short ODNs. Importantly, we conﬁrm that this
labeling method is selective for antibodies and shows no cross-
reactivity toward BSA. This selectivity is achieved using an
ODN-functionalized protein G adaptor27 (pG-ODN) that can
be photo-cross-linked to the heavy-chain region of a native
immunoglobulin G-type (IgG) antibody (Figure 1). Protein G
is part of a larger class of proteins, among them protein A and
protein L, which are able to selectively bind to a speciﬁc region
of a native IgG antibody and therefore allow site-selective
functionalization of antibodies.28−31 We previously developed,
and successfully used, this strategy to decorate DNA
nanostructures with antibodies and Fc-functionalized pro-
teins.32 In this study, we optimized the ODN coupling
eﬃciency to protein G, which allowed the direct conjugation of
unpuriﬁed pG-ODN constructs to a native antibody, making
multiplexed antibody labeling eﬃcient and less time-consum-
ing. We show that this strategy is compatible with human
IgG1, mouse IgG2a, and rabbit IgG antibodies, which together
cover ≥80% of the commercially available primary antibod-
ies.33 In combination with a universal, benchtop-compatible
puriﬁcation method, we report on the successful labeling and
puriﬁcation of a subset of primary antibodies. To illustrate the
universal applicability of the coupling strategy, cellular labeling
with pG-ODN−antibody constructs is evaluated using ﬂow
cytometry and super-resolution microscopy techniques,
including stochastic optical reconstruction microscopy
(STORM)34 and DNA point accumulation for imaging in
nanoscale topography (DNA-PAINT).2 Our results show
successful cellular labeling using the pG-ODN−antibody
conjugates and underline that covalent coupling of the pG-
ODN construct to the antibody is required when multiplexed
cellular labeling is performed.
■ RESULTS AND DISCUSSION
To facilitate the eﬃcient synthesis of multiple unique pG-
ODN constructs, we ﬁrst focused on a labeling method to
couple maleimide-functionalized ODNs to protein G with a
high yield. Previous work showed that the N-terminal cysteine
formed an unreactive thiazolidine adduct during pG
expression, which limited the pG-ODN conjugation eﬃciency
to ∼15%.32 In this previous work, it was hypothesized that the
introduction of an additional amino acid before the N-terminal
cysteine would resolve this problem and increase the
conjugation eﬃciency. To this end, we site-speciﬁcally inserted
a serine N-terminal to the cysteine and found that after pG
expression, no adduct formation was observed (Figure S1).
As a result, the pG-ODN coupling eﬃciency was increased
to >90% when pG was incubated with a ﬁve-fold molar excess
of maleimide-functionalized ODN (Figure S2). Subsequently,
we investigated if the pG-ODN reaction mixture could directly
be used for antibody coupling without the initial puriﬁcation of
the pG-ODN construct. To this end, we incubated Cetuximab,
a monoclonal IgG1 antibody, with diﬀerent molar equivalents
of pG-ODN. We compared the formation of pG-ODN−
Figure 1. Schematic overview of the labeling strategy for the site-selective functionalization of primary antibodies with an oligonucleotide (ODN)
via a small protein G adaptor without cross-reactivity toward stabilizing proteins (e.g., bovine serum albumin (BSA)). Protein G is functionalized
and expressed with a cysteine coupled to a maleimide-functionalized ODN. Additionally, the protein G variant contains a non-natural amino acid,
p-benzoylphenylalanine (p-Bpa), that covalently couples the protein G-ODN conjugate to the fragment crystallizable (Fc) region of a primary
antibody, including human IgG (hIgG), mouse IgG2 (mIgG2), and rabbit IgG (rIgG), using long-wavelength UV light (365 nm). Antibody−ODN
conjugates are puriﬁed via a benchtop-compatible method and can be directly used for multiplexed cellular labeling using either ﬂow cytometry or
super-resolution microscopy.
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antibody conjugates using the unpuriﬁed pG-ODN reaction
mixture and puriﬁed pG-ODN. SDS-PAGE analysis was used
to monitor product formation, and gel band intensity analysis
showed that >80% of the heavy chains were successfully
labeled with pG-ODN using a 10-fold molar excess of
unpuriﬁed pG-ODN (Figure 2A and Figure S3). In
comparison, we observed >90% labeling eﬃciency when
puriﬁed pG-ODN was used (Figure S4). Additionally, the
lyophilization of the pG-ODN constructs did not decrease the
reported conjugation eﬃciency, making these constructs ideal
for long-term storage and shipping (Figure S5). We note that
the antibody conjugation eﬃciency (∼80%) does not match
the coupling eﬃciency observed after pG-ODN coupling
(>90%); however, we hypothesize that pG−antibody binding
is preferred over pG-ODN−antibody coupling due to the steric
hindrance and electrostatic repulsion induced by the ODN.
Nevertheless, on the basis of the observed heavy-chain labeling
eﬃciency for unpuriﬁed pG-ODN, we expect that >95% of all
antibodies (two heavy chains) contain at least one ODN
sequence.
To examine the general applicability of the pG-ODN
labeling strategy, we evaluated the coupling eﬃciency for
antibodies of diﬀerent host species. Previously, it was shown
that pG was also able to photo-cross-link to mouse IgG2a and
Rabbit IgG.27 Rabbit IgGs, in particular, are an important class
of antibodies because rabbits are the host species in which
most primary antibodies are raised.33 Incubating both mouse
IgG2a (mIgG2a) and rabbit IgG with a 10-fold excess of pG-
ODN showed successful antibody coupling, emphasizing the
universal applicability of pG-ODN labeling (Figure 2B).
Because commercially available primary antibodies are
typically supplemented with protein stabilizers (e.g., BSA,
glycerol, sodium azide), pG-ODN antibody labeling should be
compatible with the presence of these additives. BSA, in
particular, is known to interfere with more classic ODN-
labeling methods targeting functional groups in the antibody
(e.g., lysine, cysteine). Commercially available kits can be used
to remove BSA; however, these protocols rely on extensive
washing steps, resulting in the extensive loss of antibody. The
exclusive selectivity of pG-ODN towards the heavy-chain
region should overcome this problem, making the need for
BSA-free antibody solutions redundant. To test this, we
performed the coupling of an antibody to pG-ODN in the
presence of 0.07% (w/v) BSA. As expected, the labeling of
Cetuximab in the presence of BSA did not result in cross-
reactivity, conﬁrming the selectivity of pG-ODN constructs
(Figure 2C). Additionally, we evaluated the coupling eﬃciency
of pG-ODN in the presence of other common antibody
additives, including TWEEN-20, glycerol, and sodium azide.
Sodium azide is known to quench the reactive triplet state of p-
Bpa and is therefore likely to inhibit the pG-ODN cross-
linking.35 Whereas TWEEN-20 did not alter the coupling
eﬃciency, both glycerol and sodium azide inhibited the
formation of pG-ODN−antibody constructs (Figure S6).
However, buﬀer exchange of the antibody using ultraﬁltration
to a glycerol/sodium azide free buﬀer did restore the coupling
eﬃciency. From this, we conclude that the pG-ODN labeling
strategy can be used in combination with commercially
available antibodies.
We next focused on the development of a universal
puriﬁcation approach to remove excess pG-ODN. To this
extent, we systematically evaluated diﬀerent puriﬁcation
methods that either focus on size-based separation or are
speciﬁcally designed for antibody puriﬁcation. First, we tested
the separation of pG-ODN−antibody constructs and pG-ODN
using size-exclusion chromatography (SEC). The relatively
large diﬀerence in molecular weight between pG-ODN and
labeled antibodies, 15 and 180 kDa, respectively, should
provide enough separation to eﬀectively purify the pG-ODN−
antibody. To this end, we applied a high-performance liquid
chromatography (HPLC) system with a size exclusion column
that has a fractionation range between 5 × 103 and 1.25 × 106
Figure 2. Antibody−ODN labeling and puriﬁcation. (A) Protein G (pG) was conjugated to a 20 nt 3′-maleimide-functionalized ODN. Human
IgG1 (hIgG1) was incubated with varying molar equivalents of unpuriﬁed pG-ODN, and the labeling eﬃciency was analyzed and compared with
puriﬁed pG-ODN under reducing SDS-PAGE conditions. Without pG-ODN puriﬁcation, ∼20% of the heavy chains were coupled to pG instead of
pG-ODN. (B) Reducing SDS-PAGE analysis of various IgG subclasses coupled to 10 equiv pG-ODN and a (C) hIgG1 antibody coupled to pG-
ODN in the presence and absence of 0.07% (w/v) bovine serum albumin (BSA). (D) Excess of pG-ODN was removed using protein-L-
functionalized magnetic beads covalently coupled to a scavenger antibody via a PEGylated bis(sulfosuccinimiyl)suberate linker (BS(PEG)5). The
average recovery (green) and contamination (red) of the magnetic beads (MBs) were compared to ultraﬁltration (UF). Error bars represent SD (n
= 3).
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Da. Using this approach, the pG-ODN−antibody conjugate
was well-separated from unreacted pG-ODN (Figure S7).
However, despite the excellent separation, we note that HPLC
requires specialized equipment. Moreover, HPLC puriﬁcation
results in high sample dilution, making this method less
appropriate for small sample volumes, which is typically the
case when primary, more expensive antibodies are labeled. To
address this limitation, we evaluated a second size-based
puriﬁcation technique using ultraﬁltration. We performed a
repetitive dilution concentration process using a regenerated
cellulose membrane with a 100 kDa molecular weight cutoﬀ
(MWCO). In this process, the large pG-ODN−antibody
should be retained by the membrane, whereas the smaller pG-
ODN should ﬂow through. In contrast with SEC, ultraﬁltration
resulted in limited separation of the pG-ODN−antibody and
pG-ODN with a recovery yield of 25% and contamination of
19% (Figure 2D, bottom). The recovery yield and contami-
nation percentage were calculated by gel analysis of the
puriﬁed product and known concentrations of a reference
antibody (Figure S8). To improve the separation of the pG-
ODN−antibody and the free pG-ODN, we evaluated the
performance of multiple (denaturing) washing buﬀers. Where-
as the use of diﬀerent washing buﬀers did improve the recovery
yield (68%), the separation remained limited (Figure S9).
Further optimization of this puriﬁcation process, for example,
the use of an acidic washing buﬀer, could therefore be
performed to improve the limited separation.29−31
To design a universal benchtop-compatible puriﬁcation
method, we therefore decided to turn our attention to
antibody-speciﬁc puriﬁcation methods. In addition to protein
G, several recombinant proteins are available that target
speciﬁc regions of an antibody, including proteins A and L.
Whereas protein A overlaps with the binding site of protein G,
protein L speciﬁcally binds to kappa light chains of mouse and
human IgG monoclonal antibodies.28 Using commercially
available magnetic beads functionalized with protein L, we
were able to successfully purify pG-ODN-functionalized
Cetuximab (hIgG1) from pG-ODN (Figure S10). However,
the limited compatibility of protein L with diﬀerent subclasses
or host species of antibodies prevents the general application of
this puriﬁcation method. Therefore, we developed a
puriﬁcation method that utilizes the protein L magnetic
beads to target free pG-ODN, instead of the labeled antibody.
We achieved this via the covalent attachment of a scavenging
antibody, typically a secondary, less expensive antibody, to
protein L beads by cross-linking the primary amines of both
proteins using a bis-succinimide ester-activated PEG com-
pound BS(PEG)5 (Figure 2D, top). Protein L ensures the
correct orientation of the scavenger antibody, making the Fc
region available for free pG-ODN binding. We evaluated
multiple cross-linking conditions to increase the binding
capacity of the scavenger beads and showed the successful
capture of pG-ODN (Figure S11). Subsequently, we conﬁrmed
that this method can be used to purify pG-ODN-labeled
antibodies, and after desalting of the puriﬁed mixture, a
recovery of 58% and contamination of only 3% were achieved
(Figure 2D, bottom; Figure S12). Whereas the relatively low
recovery yield could be improved by further optimization of
the washing steps, we primarily focused on the low
contamination. Additionally, we note that the recovery yield
is decreased to 30% when antibodies that have a high intrinsic
aﬃnity for protein L (hIgG, mIgG) are puriﬁed (Figure S13).
Lastly, it was shown that this scavenging approach could be
performed on a small scale (5 μg) and was compatible with Fc-
fusion proteins (Figure S14). Protein-L-functionalized mag-
netic beads, in combination with a scavenging antibody,
therefore provide an additional platform for the small-scale
puriﬁcation of antibodies from diﬀerent host species and
subtypes.
To test the activity of the pG-ODN functionalized
antibodies after labeling and puriﬁcation, we used ﬂuores-
cence-activated cell sorting (FACS) analysis. To this end, we
functionalized Cetuximab with a pG-ODN docking strand a.
Subsequently, we preincubated pG-ODN-labeled Cetuximab
that was puriﬁed using SEC, ultraﬁltration, or magnetic
scavenging beads with a CY5-functionalized ODN, a′,
complementary to the pG-ODN docking strand. Eventually,
we incubated A431 carcinoma cells, expressing high levels of
epidermal growth factor receptor (EGFR), with pG-ODN−
Cetuximab, hybridized to a CY5-labeled ODN, and subjected
them to ﬂow cytometry. In all cases, an increase in the
ﬂuorescence intensity was observed, indicating the binding of
pG-ODN−Cetuximab to the EGFR receptor (Figure 3A and
Figure S15).
To emphasize the importance of irreversible coupling, we
compared the labeling eﬃciency and cross-contamination of
antibodies labeled covalently (+hν) and noncovalently (−hν)
with pG-ODN. To this end, Cetuximab was incubated with
pG-ODN in the presence and absence of UV illumination.
Subsequently, A431 cells were incubated with pG-ODN−
Figure 3. Flow cytometric analysis of EGFR-expressing A431 cells
using 10 nM pG-ODN-functionalized Cetuximab, a, hybridized to a
CY5-functionalized ODN, a′. (A) Antibody activity after puriﬁcation
using SEC, ultraﬁltration, and magnetic beads. The ﬂuorescence
intensity of pG-ODN-Cetuximab-labeled A431 cells was compared
with that of A431 cells incubated with only pG-ODN. (B) Labeling
eﬃciency and (C) cross-contamination of pG-ODN noncovalently
(−hν) or covalently (+hν) coupled to Cetuximab. pG-ODN-
functionalized Cetuximab was incubated for 1 h with a 20 mol
equiv of a competing pG-ODN sequence. MFI represents the median
ﬂuorescence intensity, and error bars represent the SD (n = 3).
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Cetuximab to label the EGFR receptor. After labeling, a CY5-
functionalized ODN, complementary to the pG-ODN
sequence, was introduced, and the cells were analyzed using
ﬂow cytometry. The 2.2-fold diﬀerence in median ﬂuorescence
shows a clear increase in labeling eﬃciency when the antibody
is labeled covalently (Figure 3B), which underlines the
importance of irreversible labeling.
Because cellular labeling procedures are typically performed
with multiple antibodies, traces of pG-ODN present after
puriﬁcation could bind other antibodies, resulting in unwanted
cross-contamination. To evaluate the degree of cross-
contamination, we incubated noncovalently and covalently
labeled pG-ODN−Cetuximab with a 20-fold molar excess of a
competing pG-ODN docking sequence, b, for 1 h. Sub-
sequently, A431 cells were incubated with the reaction mixture,
and after labeling of the EGFR receptor, a CY5-functionalized
ODN, b′, complementary to the competing pG-ODN
sequence, was added. The observed median ﬂuorescence for
the cells that were labeled with noncovalent pG-ODN−
Cetuximab showed pG-ODN exchange resulting in cross-
contamination (Figure 3C). In contrast, when pG-ODN was
coupled covalently to Cetuximab via photoinduced coupling,
no cross-contamination was observed. Additionally, it was
shown that free Fc binding sites could be blocked during
cellular labeling using a ﬁve-fold molar excess of pG compared
to the competing pG-ODN sequence, nullifying cross-
contamination (Figure S16). These results show that multiple
pG-ODN-functionalized antibodies can be used simultane-
ously, even when the pG-ODN antibody coupling is not
quantitative and free Fc sites are still available.
Thus far, we have shown the synthesis and puriﬁcation of
pG-ODN−antibody constructs and successfully used them for
cellular labeling. Next, we tested the multiplex applicability of
the pG-ODN labeling strategy by coupling three primary
antibodies, Cetuximab, mouse IgG2a anti-CD45, and mouse
IgG2a anti-CD31, to a unique pG-ODN docking sequence, a,
b, and c, respectively. Subsequently, we performed the
simultaneous labeling of three cell types with all of the pG-
ODN functionalized antibodies, including A431 carcinoma
cells, Jurkat T cells, and human umbilical vein endothelial cells
(HUVECs) expressing EGFR, CD45, and CD31, respectively.
Because quantitative pG-ODN labeling was not observed for
all antibodies, we introduced a ﬁve-fold molar excess of pG
with respect to pG-ODN to block any remaining free Fc sites.
After cellular labeling, we introduced CY5-functionalized
ODNs, a′, b′, and c′, respectively, complementary to a speciﬁc
pG-ODN docking sequence, and analyzed the cells using ﬂow
cytometry (Figure 4A). The presence of only one distinct
ﬂuorescent population per CY5-functionalized strand showed
the successful labeling of targets without the exchange of pG-
ODN sequences, verifying that pG-ODN−antibody conjugates
are suitable for multiplexed cellular labeling and imaging
(Figure 4B).
Although ﬂow cytometry is an excellent tool to study cell
populations, it is unable to provide a detailed view of the
structure and organization of subcellular components. Super-
resolution techniques, however, are able to visualize cellular
targets with nanometer precision and therefore have the
potential to increase our understanding of cell structure and
function. DNA-PAINT and, in particular, exchange-PAINT,
rely on the use of antibodies functionalized with a unique
ODN to achieve multiplexed super-resolution imaging with a
spatial resolution down to ∼5 nm.2,36 To illustrate that pG-
ODN-functionalized primary antibodies could be directly used
for DNA-PAINT, we demonstrated in situ imaging in a ﬁxed
A431 carcinoma cell using pG-ODN-functionalized Cetuximab
that was puriﬁed using SEC (Figure 5A). We obtained super-
resolution images of the EGFR receptor and observed little
nonspeciﬁc binding when a noncomplementary imager strand
was used (Figure 5B and Figure S17). Recently, Jungmann and
coworkers also successfully obtained super-resolution images
when using ODN-functionalized protein A and G variants as
secondary, noncovalent labeling reagents for DNA-PAINT.37
Because pG-ODN is covalently coupled to the antibody using
UV light, we additionally investigated whether the pG-ODN
antibody coupling is reversed when the construct is exposed to
high laser intensity, as those employed during DNA-PAINT.
To validate the stability of the pG-ODN−antibody construct,
we quantiﬁed the number of localizations during image
acquisition over the course of 8 min (Figure 5C). The
observed number of localizations remained constant over time,
conﬁrming that the photoconjugated pG-ODN−antibody
construct is stable when exposed to high laser intensity. This
result also allowed the use of pG-ODN−antibody constructs
for cellular staining in combination with direct STORM
(dSTORM), which requires high illumination power.
Successful dSTORM images of the EGFR receptor on A431
cells were acquired using a complementary CY5-functionalized
imager strand, hybridized to a pG-ODN−Cetuximab construct
(Figure 5D and Figure S18). Taken together, these results
show the compatibility of the pG-ODN labeling approach with
super-resolution techniques, including DNA-PAINT and
dSTORM.
Figure 4. Characterization of protein G-ODN cross-talk. (A)
Cetuximab, anti-CD45, and anti-CD31 are labeled in parallel with a
unique pG-ODN construct, containing ODN sequences a, b, and c,
respectively. Subsequently, the pG-ODN-labeled antibodies are
pooled, and cells expressing a speciﬁc target protein are incubated
with the antibody pool. Eventually, CY5-labeled ODNs, a′, b′, and c′,
respectively, complementary to the unique pG-ODN sequence, are
used to detect the presence of each antibody on the cell surface. (B)
Flow cytometric analysis of three cell lines (A431, Jurkat T cells, and
HUVECs) expressing EGFR, CD45, and CD31, respectively. Cells
were incubated with 10 nM of the antibody pool containing pG-
ODN-labeled Cetuximab, mouse IgG2a anti-CD45, and mouse IgG2a
anti-CD31 and subsequently labeled with 100 nM of a CY5-
functionalized ODN.
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■ CONCLUSIONS
In this work, we have developed a generally applicable ODN−
antibody coupling method using a small protein G adaptor that
site-selectively targets the heavy chain of an IgG antibody. We
successfully demonstrated pG-ODN labeling of antibodies
from diﬀerent host species without cross-reactivity towards
BSA. Importantly, we showed that the pG-ODN labeling did
not aﬀect the native function of the antibody. In combination
with the universal, benchtop-compatible puriﬁcation strategy
using magnetic beads, this ODN labeling method is directly
applicable to commercially available primary antibodies.
Because multiple pG-ODN conjugates can be constructed in
parallel and lyophilized without a loss of function, the potential
of the pG-ODN labeling strategy lies in the synthesis of a
library of pG-ODN constructs that can directly be used for
antibody labeling. This could eventually facilitate the
implementation of the multiplexing abilities of DNA-based
read-out methods for the detection of a large variety of
subcellular components and make these methods accessible for
a broader scientiﬁc community. Additionally, we envision the
use of pG-ODN−antibody constructs in more quantitative
imaging applications, owing to the unique ability of pG-ODN
conjugates to selectively label an antibody with a controlled
number of ODNs.
■ MATERIALS AND METHODS
Recombinant Protein Cloning, Expression, and
Puriﬁcation. A pET28a(+) vector encoding the pG gene as
reported previously32 was site-speciﬁcally mutated by the
insertion of an N-terminal serine using the QuikChange
Lightning multi site-directed mutagenesis kit (Agilent)
according to the manufacturer’s instructions using the
following forward and reverse primers (ser codon underlined),
5′-TTTAAGAAGGAGATATAACATGAGTTGCTGGTCC-
CATCCG-3′ and 5′-CGGATGGGACCAGCAACTCATGT-
TATATCTCCTTCTTAAAG-3′, respectively. Insertion was
conﬁrmed by a DNA sequencing service provided by StarSEQ
(Mainz, Germany). Plasmid DNA of the pG gene was
cotransformed with the pEVOL-pBpF vector, encoding for
the orthogonal aminoacyl tRNA synthetase/tRNA pair (kindly
provided by Peter Schultz), into E. coli BL21(DE3) (Novagen)
for protein expression. A single colony of freshly transformed
cells was cultured at 37 °C in 500 mL of 2xYT medium
supplemented with 50 μg/mL kanamycin (Merck) and 25 μg/
Figure 5. Protein G-ODN−antibody conjugates for applications in super-resolution microscopy. (A) A431 carcinoma cells are labeled with a pG-
ODN−Cetuximab construct containing either a short (11 nt) or a long (20 nt) docking strand. Subsequently, the labeled cells are ﬁxated to a glass
slide, and super-resolution images are obtained using the transient binding of a short imager strand (DNA-PAINT) or using a long irreversible
binder in combination with a photoswitchable dye (dSTORM). (B) DNA-PAINT super-resolution image obtained using ATTO647N-
functionalized imager strands (20 000 frames, 20 Hz frame rate). A zoom-in on two deﬁned areas shows the distribution of EGFR receptors. (C)
Number of localizations observed over the course of 8 min during a DNA-PAINT acquisition using complementary (c) or non-complementary
(n.c.) imager strands. (D) Super-resolution image obtained with dSTORM using a CY5-functionalized imager strand (20 000 frames, 65.5 Hz
frame rate), including a zoom-in on two deﬁned areas that show the distribution of EGFR receptors. Scale bars: 5 and 1 μm for the zoom-in images.
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mL chloramphenicol (Sigma-Aldrich). When the OD600 of the
culture reached ∼0.6, protein expression was induced by the
addition of β-D-1-thiogalactopyranoside (IPTG, Applichem),
arabinose (Sigma-Aldrich), and the unnatural amino acid p-
BpA (Bachem) in a ﬁnal concentration of 1 mM, 0.02% (w/v),
and 1 mM, respectively. The induced protein expression was
carried out for ∼18 h at 25 °C, and subsequently, the cells
were harvested by centrifugation at 10 000g for 10 min at 4 °C.
The cell pellet was resuspended in BugBuster (5 mL/g pellet,
Merck) supplemented with benzonase (5 μL/g pellet, Merck)
and incubated for 45 min on a shaking table. The suspension
was centrifugated at 40 000g for 30 min at 4 °C, and the
supernatant was subjected to Ni-NTA aﬃnity chromatography
on a gravity column. His-tagged pG was loaded on the column
and washed with washing buﬀer (1× PBS, 370 mM NaCl, 10%
(v/v) glycerol, 20 mM imidazole, pH 7.4) before elution with
his-elution buﬀer (1× PBS, 370 mM NaCl, 10% (v/v) glycerol,
250 mM imidazole, pH 7.4). Subsequently, the Ni-NTA
elution fraction was loaded on a Strep-Tactin column, washed
with washing buﬀer (100 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA, pH 8.0), and eluted using wash buﬀer supplemented
with 2.5 mM desthiobiotin (IBA Life Sciences). Proteins were
stored at −80 °C in 1 mL aliquots of 50 μM at −80 °C in a
buﬀer containing 100 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA, and 2 mM TCEP at pH 8.0. The concentration of pG
was calculated on the basis of the absorption at 280 nm (ND-
1000, Thermo Scientiﬁc), assuming an extinction coeﬃcient of
15 470 M−1 cm−1, and the purity of pG was assessed on
reducing SDS-PAGE and liquid chromatography quadrupole
time-of-ﬂight mass spectrometry (Q-Tof).
Preparation of Reaction ODNs. In a typical reaction, to a
solution of 10 nmol ODN in water (10 μL) was added 1×
PBS, pH 7.2 (30 μL) and 100 nmol Sulfo-SMCC (Thermo
Scientiﬁc) in DMSO (40 μL). The reaction was incubated at
850 rpm for 2 h at 20 °C. Excess Sulfo-SMCC was removed
using two rounds of ethanol precipitation. SMCC-labeled
ODNs were precipitated by the addition of 10% (v/v) 5 M
NaCl and 300% (v/v) ice-cold EtOH and incubating for 75
min at −30 °C. The reaction mixture was centrifuged at
19 000g for 30 min at 4 °C, the pellet was reconstituted in 1×
PBS (pH 7.2), and the precipitation was repeated. After
centrifugation, the pellet was washed in 95% (v/v, in water)
ice-cold EtOH, centrifuged at 19 000g for 15 min, and
lyophilized.
General Procedure for the Conjugation of ODN to
pG. For the conjugation of pG to a SMCC-functionalized
ODN, an aliquot of pG was buﬀer-exchanged to (100 mM
sodium phosphate, 25 μM TCEP, pH 7) using a PD10
desalting column (GE Healthcare). Subsequently, desalted pG
was concentrated to a ﬁnal concentration of 50 μM using
Amicon 3 kDa MWCO centrifugal ﬁlters (Merck Millipore).
Ten nmol lyophilized SMCC-functionalized ODN was
reconstituted in 40 μL of 50 μM pG (2 nmol), resulting in a
ﬁve times excess of maleimide−ODN. The reaction was
shaken at 850 rpm for 3 h at 20 °C. The coupling eﬃciency
was assessed using SDS-PAGE under nonreducing conditions.
The puriﬁcation, if applicable, of pG-ODN was performed
using fast protein liquid chromatography (FPLC, ÄKTA
Prime, GE Healthcare) with an anion-exchange HiTrap Q
HP column (1 mL, GE Healthcare) using a salt gradient with a
start and end concentration of 100 and 500 mM NaCl in 50
mM Tris-HCl (pH 7.5), respectively. Elution fractions were
collected and analyzed by measuring online absorption at 280
nm and SDS-PAGE under nonreducing conditions. pG-ODN
conjugates were aliquoted and stored at −80 °C.
General Procedure for pG-ODN Antibody Labeling.
Before the conjugation of the antibody to the pG-ODN, all
antibodies were buﬀer-exchanged to 1× PBS (pH 7.4) using
Amicon 10 kDa MWCO centrifugal ﬁlters (Merck Millipore).
In the absence of BSA: In a typical reaction for SDS-PAGE gel
analysis, a 10 μL aliquot containing 0.4 μM of antibody and 4
μM of pG-ODN was exposed for 1 h to UV light (λ = 365 nm)
at 4 °C.
In the presence of BSA: For the conjugation of the antibody to
pG-ODN in the presence of BSA, the pG-ODN reaction
mixture was ﬁrst incubated with 15 nmol of DTT and shaken
at 850 rpm for 30 min at 20 °C to deactivate remaining
maleimide−ODNs. Subsequently, pG-ODN was buﬀer-ex-
changed using a Zeba spin desalting column, 7000 MWCO,
0.5 mL (Thermo Scientiﬁc).
General Procedure for the Antibody Functionaliza-
tion of Protein L Magnetic Beads. The scavenging
antibody Cetuximab (Erbitux, Merck) was buﬀer-exchanged
to conjugation buﬀer (100 mM sodium phosphate, 70 mM
NaCl, 0.05% TWEEN-20 (v/v), pH 8.0) using a Zeba spin
desalting column (7000 MWCO, 0.5 mL, Thermo Scientiﬁc)
according to the manufacturer’s instructions. In a typical
reaction, 25 μL of Pierce protein L magnetic beads was added
to 75 μL of conjugation buﬀer. The beads were washed twice
in 200 μL of conjugation buﬀer, after which the magnetic
beads were incubated with 50 μg of scavenging antibody in a
ﬁnal volume of 250 μL. The tube was rotated for 1 h at room
temperature. To cross-link the antibody to the beads, 0.5 μL of
250 mM BS(PEG)5 (Thermo Scientiﬁc) (dissolved in dry
DMSO) was added to the reaction mixture. Cross-linking was
performed for 30 min in a rotating wheel at room temperature,
after which the reaction was deactivated by the addition of 25
μL of 1 M Tris-HCl (pH 7.5). Deactivation was performed for
15 min in a rotating wheel at room temperature. Subsequently,
the magnetic beads were collected with a magnetic stand, and
the supernatant was discarded. The scavenging beads were
incubated two times for 5 min with 200 μL of washing buﬀer
(100 mM Tris-HCl, 1 M NaSCN, pH 7.5), subsequently
washed two times with 200 μL of storage buﬀer (1× PBS,
0.05% TWEEN-20 (v/v), pH 7.4), and stored at 4 °C.
General Procedure for the Puriﬁcation of pG-ODN
Functionalized Antibody. This procedure is optimized to
purify 12.5 μL of 4 μM antibody−pG-ODN from 40 μM
uncoupled pG-ODN using 25 μL of magnetic scavenging
beads. Twenty-ﬁve μL of scavenging beads was washed two
times in binding buﬀer (1× PBS, 870 mM NaCl, 0.05%
TWEEN-20 (v/v), pH 7.4). The beads were redissolved in
37.5 μL of binding buﬀer, and 12.5 μL of the antibody−pG-
ODN reaction mixture was added and incubated for 15 min in
a rotating wheel at room temperature. The scavenging beads
were collected with a magnetic stand, and the supernatant was
discarded. Subsequently, the beads were incubated two times
for 5 min with 200 μL of washing buﬀer (100 mM Tris-HCl, 1
M NaSCN, pH 7.5). The whole process was repeated two
more times to remove all pG-ODN. Amicon 50 kDa MWCO
centrifugal ﬁlters were used to purify the antibody−pG-ODN
conjugates from unreacted maleimide−ODN conjugates and
buﬀer-exchange the puriﬁed conjugates to 1× PBS, pH 7.4.
The removal of the pG-ODN conjugate and the recovery of
the antibody-coupled pG-ODN were assessed based on the gel
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band intensity analysis using SDS-PAGE under reducing
conditions.
Cellular Labeling for Flow Cytometry. A431, Jurkat T,
and HUVECs were cultured in a 175 cm2 ﬂask. Cells were
harvested at a conﬂuency of ∼80%, washed in labeling buﬀer
(1× PBS, 0.1% BSA (w/v), pH 7.4), and diluted to a ﬁnal
concentration of 3.5 × 106 cells/mL in labeling buﬀer.
Subsequently, 12.5 μL of the cell suspension was incubated
in a ﬁnal volume of 250 μL of labeling buﬀer containing 10 nM
of pG-ODN-labeled antibody. The reaction mixture was
shaken at 400 rpm for 30 min at room temperature.
Subsequently, the labeled cells were centrifuged for 5 min at
1500g, and the supernatant was removed. The pelleted cells
were redissolved in labeling buﬀer containing 100 nM of the
complementary CY5-labeled ODN. The reaction mixture was
incubated and centrifuged as previously described and
subsequently analyzed using ﬂow cytometry. For the multi-
plexed experiment (Figure 4), the labeling buﬀer was
supplemented with 1.5 μM pG.
Super-Resolution Sample Preparation and Imaging.
A431 cells (ATCCCRL-1555) were seeded on an eight-well
glass-bottomed μ-slide (ibidi, Germany) overnight. Live-cell
immunolabeling started with 5 min of acclimation of the cells
at room temperature, followed by 5 min of acclimation at 4 °C.
Cells were incubated for 45 min at 4 °C in DMEM/3% BSA
with 1 μg/mL of pG-ODN−Cetuximab. Then, three 5 min
washes with PBS at 4 °C were followed by formalin 5% and
glutaraldehyde 0.25% ﬁxation for 10 min. Ultimately, cells were
washed three times for 5 min with PBS and stored in the fridge
before imaging. Super-resolution images were acquired using a
Nikon N-STORM microscope in total internal reﬂection
ﬂuorescence (TIRF) mode. The system was equipped with a
Nikon 100×, 1.49 NA oil immersion objective and an Andor
iXON3 camera. Images were acquired onto a 256 × 256 pixel
region (40.96 × 40.96 μm) and analyzed with NIS Element
Nikon software. Samples were illuminated with a 647 nm laser
at 140 mW, 16 ms, and 20 000 frames for STORM or 70 mW,
50 ms, and 20 000 frames for DNA-PAINT. To perform
STORM imaging, we used a speciﬁc buﬀer to induce dye
photoswitching: 5% w/v glucose, 100 mM cysteamine, 0.5 mg/
mL glucose oxidase, and 40 μg/mL catalase in PBS. For DNA-
PAINT imaging, we diluted DNA imager ATTO647N to 1 nM
in PBS (500 mM NaCl).
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